Cardiovasc Diabetol 20:32 Hundertmark MJ, Agbaje OF, Coleman R, George JT, Grempler R, Holman RR, Lamlum H, Lee J, Milton JE, Niessen HG, Rider O, Rodgers CT, Valkovi L, Wicks E, Mahmod M, Neubauer S (2021) Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
Extensive long-term studies have evaluated both safety and efficacy
Vomiting : Some may experience this, particularly when first starting treatment
The exact cause of this pain remains unclear, possibly linked to the physiological changes induced by the medication
Possible Side Effects And Safety Considerations GLP-1 injections may cause side effects
Regular treatments can help maintain peak wellness and prevent future health issues